We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
+1.96%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
AUM
$25.3B
AUM Growth
+$814M
Cap. Flow
+$613M
Cap. Flow %
2.42%
Top 10 Hldgs %
16.08%
Holding
3,081
New
5
Increased
1,358
Reduced
932
Closed
769

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$31.9M
2
AAPL icon
Apple
AAPL
+$24.9M
3
T icon
AT&T
T
+$21.1M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$20.2M
5
BIIB icon
Biogen
BIIB
+$19.7M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$34M
2
RHT
Red Hat Inc
RHT
+$22.2M
3
HSBC icon
HSBC
HSBC
+$20.3M
4
APC
Anadarko Petroleum
APC
+$19.9M
5
CAJ
Canon, Inc.
CAJ
+$16.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Financials 16.76%
3 Healthcare 12.56%
4 Consumer Discretionary 10.05%
5 Communication Services 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANF icon
1676
Abercrombie & Fitch
ANF
$4.42B
$576K ﹤0.01%
36,942
-4,503
-11% -$75.2K
FULT icon
1677
Fulton Financial
FULT
$4.66B
$576K ﹤0.01%
35,604
+4,230
+13% +$68.8K
INN
1678
Summit Hotel Properties
INN
$746M
$576K ﹤0.01%
49,698
+270
+0.5% +$3.09K
SNAP icon
1679
Snap
SNAP
$7.89B
$576K ﹤0.01%
36,476
+488
+1% +$7.81K
SXT icon
1680
Sensient Technologies
SXT
$5.26B
$575K ﹤0.01%
8,374
-1,071
-11% -$73K
RVNC
1681
DELISTED
Revance Therapeutics, Inc.
RVNC
$575K ﹤0.01%
44,283
+9,732
+28% +$119K
ALX
1682
Alexander's
ALX
$1.3B
$573K ﹤0.01%
1,645
-64
-4% -$23.5K
HCSG icon
1683
Healthcare Services Group
HCSG
$1.6B
$573K ﹤0.01%
23,559
+10,260
+77% +$259K
RBA icon
1684
RB Global
RBA
$20.4B
$573K ﹤0.01%
14,352
-595
-4% -$22.1K
FOX icon
1685
Fox Class B
FOX
$21.8B
$572K ﹤0.01%
18,123
+4,045
+29% +$140K
CRI icon
1686
Carter's
CRI
$1.42B
$568K ﹤0.01%
6,226
-342
-5% -$31.2K
PDCO
1687
DELISTED
Patterson Companies, Inc.
PDCO
$568K ﹤0.01%
31,871
-35,728
-53% -$667K
HBNC icon
1688
Horizon Bancorp
HBNC
$1.04B
$565K ﹤0.01%
32,572
+3,473
+12% +$57.8K
THRM icon
1689
Gentherm
THRM
$1.25B
$565K ﹤0.01%
13,762
-575
-4% -$22.7K
HRI icon
1690
Herc Holdings
HRI
$5.02B
$564K ﹤0.01%
12,124
+1,312
+12% +$57K
VRTU
1691
DELISTED
Virtusa Corporation
VRTU
$564K ﹤0.01%
15,655
-561
-3% -$22.5K
MITT
1692
TPG Mortgage Investment Trust
MITT
$222M
$562K ﹤0.01%
12,362
+713
+6% +$33.6K
PMT
1693
PennyMac Mortgage Investment
PMT
$822M
$562K ﹤0.01%
25,302
+2,510
+11% +$55.3K
TREE icon
1694
LendingTree
TREE
$447M
$562K ﹤0.01%
1,809
-262
-13% -$89.3K
AAON icon
1695
Aaon
AAON
$7.3B
$560K ﹤0.01%
18,281
+1,164
+7% +$37.6K
GVA icon
1696
Granite Construction
GVA
$5.29B
$559K ﹤0.01%
17,383
+5,803
+50% +$201K
WTFC icon
1697
Wintrust Financial
WTFC
$10.8B
$558K ﹤0.01%
8,641
-2,768
-24% -$184K
SXI icon
1698
Standex International
SXI
$3.59B
$556K ﹤0.01%
7,629
-407
-5% -$28.2K
TTMI icon
1699
TTM Technologies
TTMI
$12B
$556K ﹤0.01%
45,580
-3,787
-8% -$40.6K
UFCS icon
1700
United Fire Group
UFCS
$1.32B
$554K ﹤0.01%
11,799
+119
+1% +$5.66K

Similar funds

Aperio Group's Q3 2019 Portfolio in Review

As of Q3 2019, Aperio Group held 3,081 positions worth $25.3B, up 3.3% from $24.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Aperio Group's Q3 2019 filing shows 5 new, 1,358 increased, 932 reduced and 769 closed positions. Its largest new stake was Genmab: 211,272 shares worth $4.28M. The largest sale was Pfizer, an estimated $34M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Aperio Group's largest Q3 2019 buy was Genmab: 211,272 shares worth $4.28M.
  • Aperio Group added most to Microsoft in Q3 2019, an estimated $31.9M increase.
  • Aperio Group's biggest Q3 2019 reduction was Pfizer, cutting an estimated $34M.
  • Aperio Group fully exited Red Hat Inc in Q3 2019, selling an estimated $22.2M.
  • Aperio Group's ten largest holdings make up 16% of its $25.3B portfolio in Q3 2019.
  • Aperio Group opened 5 new positions and closed 769 in Q3 2019.
  • Aperio Group's portfolio value rose 3.3% quarter-over-quarter to $25.3B.

Based on Aperio Group's 13F filing for Q3 2019, filed 6 Nov 2019.